What is RAIU (Radioactive Iodine Uptake)?
RAIU is a nuclear medicine test that directly measures thyroid gland activity by quantifying how much radioactive iodine (typically I-123 or I-131) the thyroid absorbs after oral administration, typically measured at specific time points (2,4, and 24 hours post-administration). 1
How the Test Works
The test involves:
- Oral administration of a small amount of radioactive iodine (I-123 preferred over I-131 due to superior imaging quality) 1
- Measurement at standardized time intervals: typically at 2,4, and 24 hours after administration 2, 3
- Quantification using a scintillation probe that counts radioactivity over the thyroid and compares it to a standard dose to calculate the percentage uptake 4
Primary Clinical Applications
When RAIU is Indicated:
Thyrotoxicosis evaluation - RAIU is the preferred test for determining the cause of thyrotoxicosis when the diagnosis is ambiguous or when toxic adenoma or multinodular goiter is suspected 1. The test directly measures thyroid activity rather than inferring it from blood flow (unlike Doppler ultrasound), making it superior for distinguishing:
- High uptake conditions: Graves disease, toxic adenoma, toxic multinodular goiter
- Low uptake conditions: Subacute thyroiditis, lymphocytic thyroiditis, factitious thyroid hormone ingestion, iodine-induced hyperthyroidism
Treatment planning - RAIU plays a critical role in calculating appropriate radioactive iodine therapy doses for hyperthyroidism 5. Dosimetric methods using RAIU measurements provide more precise treatment planning and lower risk of hypothyroidism compared to fixed-dose approaches 5.
Goiter with thyrotoxicosis - When a goiter is associated with thyrotoxicosis, RAIU confirms that the entire goiter consists of functioning thyroid tissue 1.
When RAIU is NOT Indicated:
Hypothyroidism - There is no role for RAIU in evaluating hypothyroidism, as all causes will show decreased uptake regardless of etiology 1. This makes the test non-discriminatory and clinically unhelpful in this setting.
Routine thyroid nodule evaluation - RAIU alone is not the primary test for thyroid nodules unless there is concurrent thyrotoxicosis.
Technical Considerations
Normal values vary but typically range around 6-15% at 6 hours and 15-35% at 24 hours in euthyroid individuals 4, 6.
Factors affecting uptake:
- Dietary iodine intake: Higher urinary iodine concentration (UIC) inversely correlates with RAIU, with patients having UIC >300 μg/L showing 15-20% reduction in uptake compared to normal iodine status 2
- Age and gender: RAIU declines with age and tends to be higher in females 2
- TSH levels: In hypothyroid states with elevated TSH, RAIU increases in a TSH-dependent manner 7
Common Pitfalls
- Iodine contamination: Recent iodinated contrast studies, amiodarone use, or high dietary iodine can suppress uptake and yield false-low results 2
- Timing of measurements: The 24-hour measurement is generally more reliable than earlier time points for clinical decision-making 4
- Reproducibility: While generally reliable, RAIU has a least significant change of approximately 1.29% at 4 hours and 0.91% at 24 hours, meaning differences below these thresholds may not be clinically meaningful 4